Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants

Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants

The presence of maternal poliovirus antibodies may interfere with the immune response to inactivated polio vaccine (IPV), and its influence on the safety of vaccination is not yet understood. A total of 1146 eligible infants were randomly assigned (1:1) to the IPV and Sabin IPV (SIPV) groups to comp...

Full description

Bibliographic Details
Main Authors:	Shuyu Gao, Mingwei Wei, Kai Chu, Jingxin Li, Fengcai Zhu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-11-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	inactivated polio vaccine maternal antibody immunogenicity safety
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2050106

Similar Items

Immunogenicity of Catch-Up Immunization with Conventional Inactivated Polio Vaccine among Japanese Adults
by: Shinji Fukushima, et al.
Published: (2022-12-01)

COMPARATIVE EVALUATION OF SAFETY AND IMMUNOGENICITY INACTIVATED VACCINE FOR POLYOMIELITIS PREVENTION (NETHERLANDS) AND VACCINE «IMOVAX POLIO» (FRANCE) IN CHILDREN USING TRIPLE IMMUNIZATION
by: I. V. Feldblyum, et al.
Published: (2019-08-01)

Immunogenicity of a combined schedule of trivalent oral and inactivated polio vaccines in South African infants
by: Shelina Moonsamy, et al.
Published: (2019-07-01)

Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains
by: Rong Tang, et al.
Published: (2019-05-01)

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
by: Lairun Jin, et al.
Published: (2022-11-01)

Comparison of the Immunogenicity and Safety of Three Enhanced Inactivated Poliovirus Vaccines from Different Manufacturers in Healthy Korean Infants: A Prospective Multicenter Study
by: Byung Ok Kwak, et al.
Published: (2020-04-01)

In-Vitro Inactivation of Sabin-Polioviruses for Development of Safe and Effective Polio Vaccine
by: Asmaa A. Abd-Elghaffar, et al.
Published: (2020-10-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011-02-01)

A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine
by: Rong Tang, et al.
Published: (2020-11-01)

Promising opportunities to improve polio vaccines
by: E. E. Evreinova, et al.
Published: (2022-07-01)

Comparison of Neutralizing Antibody Response to Type 1 Polio Virus on Healthy Infants Receiving either Oral Monovalen Polio Vaccine Type 1 or Oral Trivalen Polio Vaccine Given with Basic DTP/Hb Immunization
by: Edim Hartati, et al.
Published: (2010-04-01)

Use of a fractional dose of inactivated polio vaccine (fIPV) to increase IPV coverage among children under 5 years of age in Somalia
by: Khaliif Nouh, et al.
Published: (2024-03-01)

An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan
by: Umar Farooq Bullo, et al.
Published: (2021-01-01)

Post-polio eradication: vaccination strategies and options for India
by: Jayakrishnan Thayyil, et al.
Published: (2014-11-01)

Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial
by: Yan Zheng, et al.
Published: (2022-02-01)

Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis
by: Guihua Tang, et al.
Published: (2018-11-01)

Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study
by: Qiao Guo, et al.
Published: (2022-12-01)

Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
by: Ting Zhao, et al.
Published: (2021-08-01)

Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
by: Han X, et al.
Published: (2022-04-01)

Polio eradication: Current status and challenges
by: Soumyadeep Bhaumik
Published: (2012-01-01)

Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
by: Sharad Agarkhedkar, et al.
Published: (2019-04-01)

Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study
by: Huiqiong Zeng, et al.
Published: (2022-11-01)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
by: Yaping Chen, et al.
Published: (2022-12-01)

Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine
by: Cecilia Montalban, et al.
Published: (2018-03-01)

Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication
by: Prashant Kumar, et al.
Published: (2022-12-01)

Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
by: Long Chiau Ming, et al.
Published: (2020-07-01)

Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation
by: Yuemei Hu, et al.
Published: (2018-06-01)

Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
by: Alexander W Kay, et al.
Published: (2015-06-01)

A Comparison with Adverse Events Following Immunization Associated with Sabin-Strains and Salk-Strains Inactivated Polio Vaccines in Zhejiang Province, China
by: Huakun Lv, et al.
Published: (2022-02-01)

Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3–8 Years
by: Yunfeng Shi, et al.
Published: (2023-10-01)

Exploring Knowledge and Perceptions of Polio Disease and Its Immunization in Polio High-Risk Areas of Pakistan
by: Muhammad Atif Habib, et al.
Published: (2023-07-01)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
by: Juan Li, et al.
Published: (2021-10-01)

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial
by: Akram Ansarifar, et al.
Published: (2023-12-01)

The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity
by: Maryam Keshtkar-Jahromi, et al.
Published: (2020-11-01)

Immunogenicity and safety of the Southern Hemisphere 2015 formulation of Vaxigrip®
by: Mathilde Latreille-Barbier, et al.
Published: (2017-11-01)

The legacy of polio: 2 cases of post-polio syndrome and review
by: Katherine A. Mafla-Ayub, et al.
Published: (2022-07-01)

Immunization of Nile Tilapia (<i>Oreochromis niloticus</i>) Broodstock with Tilapia Lake Virus (TiLV) Inactivated Vaccines Elicits Protective Antibody and Passive Maternal Antibody Transfer
by: Thao Thu Mai, et al.
Published: (2022-01-01)

Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial
by: Jingjun Qiu, et al.
Published: (2017-06-01)

Last fight of wild polio in Africa: Nigeria’s battle
by: Yusuff Adebayo Adebisi, et al.
Published: (2020-11-01)

Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models
by: Huayue Ye, et al.
Published: (2020-11-01)